We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $5.24M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
10% less funds holding
Funds holding: 20 → 18 (-2)
25% less capital invested
Capital invested by funds: $6.95M → $5.24M (-$1.71M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SCM
Sio Capital Management
New York
|
-$1.32M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$320K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$26K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.52K |
